(FC) Bioquímica y Genética

2001

1. Additional cytogenetic changes do not influence the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with an ATRA plus anthracycline-based protocol. A report from the spanish group PETHEMA

   Haematologica, Vol. 86, Núm. 8, pp. 807-813

2. Amplification of ERBB2, RARA, and TOP2A genes in a myelodysplastic syndrome transforming to acute myeloid leukemia

   Cancer Genetics and Cytogenetics, Vol. 127, Núm. 2, pp. 174-176

3. Cancer and diabetes: Two pathological conditions in which adrenomedullin may be involved

   Peptides, Vol. 22, Núm. 11, pp. 1719-1729

4. Comparative genomic hybridization and amplotyping by arbitrarily primed PCR in stage A B-CLL

   Cancer Genetics and Cytogenetics, Vol. 130, Núm. 1, pp. 8-13

5. Complement Factor H Is a Serum-binding Protein for Adrenomedullin, and the Resulting Complex Modulates the Bioactivities of Both Partners

   Journal of Biological Chemistry, Vol. 276, Núm. 15, pp. 12292-12300

6. Cytogenetic and molecular characterization of a patient with simultaneous B-cell chronic lymphocytic leukemia and peripheral T-cell lymphoma

   American Journal of Hematology, Vol. 68, Núm. 4, pp. 276-279

7. Development of new assays and improved procedures for the purification of recombinant human chymase

   European Journal of Biochemistry, Vol. 268, Núm. 22, pp. 5885-5893

8. Effects of loop diuretics on angiotensin II-stimulated vascular smooth muscle cell growth

   Nephrology Dialysis Transplantation, Vol. 16, Núm. SUPPL. 1, pp. 14-17

9. Estudio del gen HFE en una familia Española con hemocromatosis hereditaria

   Medicina Clinica, Vol. 116, Núm. 3, pp. 100-103

10. Evidence for pigment epithelium-derived factor receptors in the neural retina

    Investigative Ophthalmology and Visual Science, Vol. 42, Núm. 13, pp. 3287-3293

11. Expression of the adrenomedullin binding protein, complement factor H, in the pancreas and its physiological impact on insulin secretion

    Journal of Endocrinology, Vol. 170, Núm. 3, pp. 503-511

12. Expression of the protein product of the PCPH proto-oncogene in human tumor cell lines

    Radiation Research, Vol. 155, Núm. 1, pp. 181-187

13. Factors affecting the dimerization of the p66 form of HIV-1 reverse transcriptase

    European Journal of Biochemistry, Vol. 268, Núm. 5, pp. 1163-1172

14. Frequent gain of chromosome 19 in megakaryoblastic leukemias detected by comparative genomic hybridization

    Genes Chromosomes and Cancer, Vol. 32, Núm. 3, pp. 285-293

15. Identificación de nuevos marcadores citogenéticos con valor pronóstico en cáncer de mama

    Anales del sistema sanitario de Navarra, Vol. 24, Núm. 1, pp. 25-37

16. Identification and analysis of the elements involved in the regulation of the promoter activity of the human gene of subunit p22phox

    Investigacion Cardiovascular, Vol. 4, Núm. 1, pp. 66-77

17. Identification of new translocations involving ETV6 in hematologic malignancies by fluorescence in situ hybridization and spectral karyotyping

    Genes Chromosomes and Cancer, Vol. 31, Núm. 2, pp. 134-142

18. Identity between the PCPH proto-oncogene and the CD39L4 (ENTPD5) ectonucleoside triphosphate diphosphohydrolase gene.

    International journal of oncology, Vol. 19, Núm. 6, pp. 1249-1254

19. Insertion (22;9)(q11;q34q21) in a patient with chronic myeloid leukemia characterized by fluorescence in situ hybridization

    Cancer Genetics and Cytogenetics, Vol. 125, Núm. 2, pp. 167-170

20. Is the balance between nitric oxide and superoxide altered in spontaneously hypertensive rats with endothelial dysfunction?

    Nephrology Dialysis Transplantation, Vol. 16, Núm. SUPPL. 1, pp. 2-5